# OnCo record nct06998407 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06998407/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06998407", "NCT06998407" ;
  schema:name "ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors"@en ;
  schema:alternateName "ORION-1"@en ;
  schema:description "A phase 1/2 trial of AVZO-021 and Fulvestrant in advanced solid tumours, run by Avenzo Therapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06998407/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06998407> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2025-08-20" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/avzo-021/>, <https://onco.cc/drugs/fulvestrant/>, <https://onco.cc/drugs/avzo-023/> ;
  onco:companies <https://onco.cc/companies/avenzo/> .